{"id":4698,"date":"2025-10-03T14:58:58","date_gmt":"2025-10-03T12:58:58","guid":{"rendered":"https:\/\/www.access2meds.eu\/?p=4698"},"modified":"2025-10-03T14:59:01","modified_gmt":"2025-10-03T12:59:01","slug":"presentation-of-new-hta-methodological-guideline-for-slovakia-at-the-ministry-of-health","status":"publish","type":"post","link":"https:\/\/www.access2meds.eu\/es\/presentation-of-new-hta-methodological-guideline-for-slovakia-at-the-ministry-of-health\/","title":{"rendered":"Presentation of New HTA Methodological Guideline for Slovakia at the Ministry of Health"},"content":{"rendered":"\n<p>The survey focuses on access-based pricing of medicinal products. It seeks to gather insights from all stakeholders on the price Tuesday September 30th the National Institute for Value and Technologies in Healthcare in collaboration with Department of Organisation and Management in Pharmacy, Faculty of Pharmacy, Comenius University in Bratislava presented the new HTA methodological guideline for Slovakia. Professor Tom\u00e1\u0161 Tesa\u0159, Department of Organisation and Management in Pharmacy at the Pharmaceutical Faculty of Comenius University in Bratislava and National Institute for Value and Technologies in Healthcare organized the seminar. Tesa\u0159 is one of the participants in ASCERTAIN. The seminar was held at the Slovakian Ministry of Health and was opend by Minister of Health, Kamil Sasko.<\/p>\n\n\n\n<figure class=\"wp-block-gallery has-nested-images columns-default is-cropped wp-block-gallery-1 is-layout-flex wp-block-gallery-is-layout-flex\">\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"1024\" data-id=\"4700\" src=\"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2025\/10\/Meeting-ASCERTAIN-2-1024x1024.png\" alt=\"\" class=\"wp-image-4700\" srcset=\"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2025\/10\/Meeting-ASCERTAIN-2-1024x1024.png 1024w, https:\/\/www.access2meds.eu\/wp-content\/uploads\/2025\/10\/Meeting-ASCERTAIN-2-980x980.png 980w, https:\/\/www.access2meds.eu\/wp-content\/uploads\/2025\/10\/Meeting-ASCERTAIN-2-480x480.png 480w\" sizes=\"(min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) and (max-width: 980px) 980px, (min-width: 981px) 1024px, 100vw\" \/><\/figure>\n<\/figure>\n\n\n\n<p>Professor Eline Aas representing the ASCERTAIN project (Department of Health Management and Health Economics, University of Oslo, Norway) gave an overview of the ASCERTAIN projects where the is to develop open access models to improve access and affordability of innovative health technologies in Europe. The work in ASCERTAIN address several factors of relevance for the new HTA guidelines for Slovakia, where the work related to cost-effectiveness thresholds is of particular relevance.<\/p>\n\n\n\n<p>Important reflections and contributions were provided by Andr\u00e1s Incze, Akceso Advisors, Switzerland, Professor Marcin Czech, Warsaw University of Technology Business School, Poland, Professor Zolt\u00e1n Kal\u00f3, Center of Health Technology Assessment, Semmelweis University and Syreon Research Institute, Budapest, Hungary and Bertalan N\u00e9meth, Syreon Research Institute and Katar\u00edna Fedorov\u00e1, National Institute for Value and Technologies in Healthcare.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>On September 30th, the Slovak Ministry of Health hosted a seminar presenting the new national HTA methodological guideline, organized by Professor Tom\u00e1\u0161 Tesa\u0159, with contributions from ASCERTAIN and international experts highlighting the relevance of cost-effectiveness thresholds.<\/p>\n","protected":false},"author":5,"featured_media":1450,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[1],"tags":[21,14,22,23,20],"class_list":["post-4698","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-allgemein","tag-health-technologies","tag-healthcare","tag-hta","tag-iht","tag-innovative-health-technologies"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.8 (Yoast SEO v27.4) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Presentation of New HTA Methodological Guideline for Slovakia at the Ministry of Health - ASCERTAIN<\/title>\n<meta name=\"description\" content=\"On September 30th, the Slovak Ministry of Health hosted a seminar presenting the new national HTA methodological guideline, organized by Professor Tom\u00e1\u0161 Tesa\u0159, with contributions from ASCERTAIN and international experts highlighting the relevance of cost-effectiveness thresholds.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.access2meds.eu\/presentation-of-new-hta-methodological-guideline-for-slovakia-at-the-ministry-of-health\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Presentation of New HTA Methodological Guideline for Slovakia at the Ministry of Health\" \/>\n<meta property=\"og:description\" content=\"On September 30th, the Slovak Ministry of Health hosted a seminar presenting the new national HTA methodological guideline, organized by Professor Tom\u00e1\u0161 Tesa\u0159, with contributions from ASCERTAIN and international experts highlighting the relevance of cost-effectiveness thresholds.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.access2meds.eu\/presentation-of-new-hta-methodological-guideline-for-slovakia-at-the-ministry-of-health\/\" \/>\n<meta property=\"og:site_name\" content=\"ASCERTAIN\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-03T12:58:58+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-03T12:59:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/04\/iStock-825537944_Liderina-scaled-e1680608197278.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2005\" \/>\n\t<meta property=\"og:image:height\" content=\"1254\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Lena Jessen\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ASCERTAIN_EU\" \/>\n<meta name=\"twitter:site\" content=\"@ASCERTAIN_EU\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Lena Jessen\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/presentation-of-new-hta-methodological-guideline-for-slovakia-at-the-ministry-of-health\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/presentation-of-new-hta-methodological-guideline-for-slovakia-at-the-ministry-of-health\\\/\"},\"author\":{\"name\":\"Lena Jessen\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#\\\/schema\\\/person\\\/84cb4791d2eba62e68ecb7f29dba9391\"},\"headline\":\"Presentation of New HTA Methodological Guideline for Slovakia at the Ministry of Health\",\"datePublished\":\"2025-10-03T12:58:58+00:00\",\"dateModified\":\"2025-10-03T12:59:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/presentation-of-new-hta-methodological-guideline-for-slovakia-at-the-ministry-of-health\\\/\"},\"wordCount\":258,\"publisher\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/presentation-of-new-hta-methodological-guideline-for-slovakia-at-the-ministry-of-health\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.access2meds.eu\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/iStock-825537944_Liderina-scaled-e1680608197278.jpg\",\"keywords\":[\"health technologies\",\"healthcare\",\"HTA\",\"iht\",\"innovative health technologies\"],\"articleSection\":[\"Allgemein\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/presentation-of-new-hta-methodological-guideline-for-slovakia-at-the-ministry-of-health\\\/\",\"url\":\"https:\\\/\\\/www.access2meds.eu\\\/presentation-of-new-hta-methodological-guideline-for-slovakia-at-the-ministry-of-health\\\/\",\"name\":\"Presentation of New HTA Methodological Guideline for Slovakia at the Ministry of Health - ASCERTAIN\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/presentation-of-new-hta-methodological-guideline-for-slovakia-at-the-ministry-of-health\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/presentation-of-new-hta-methodological-guideline-for-slovakia-at-the-ministry-of-health\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.access2meds.eu\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/iStock-825537944_Liderina-scaled-e1680608197278.jpg\",\"datePublished\":\"2025-10-03T12:58:58+00:00\",\"dateModified\":\"2025-10-03T12:59:01+00:00\",\"description\":\"On September 30th, the Slovak Ministry of Health hosted a seminar presenting the new national HTA methodological guideline, organized by Professor Tom\u00e1\u0161 Tesa\u0159, with contributions from ASCERTAIN and international experts highlighting the relevance of cost-effectiveness thresholds.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/presentation-of-new-hta-methodological-guideline-for-slovakia-at-the-ministry-of-health\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.access2meds.eu\\\/presentation-of-new-hta-methodological-guideline-for-slovakia-at-the-ministry-of-health\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/presentation-of-new-hta-methodological-guideline-for-slovakia-at-the-ministry-of-health\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.access2meds.eu\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/iStock-825537944_Liderina-scaled-e1680608197278.jpg\",\"contentUrl\":\"https:\\\/\\\/www.access2meds.eu\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/iStock-825537944_Liderina-scaled-e1680608197278.jpg\",\"width\":2005,\"height\":1254},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/presentation-of-new-hta-methodological-guideline-for-slovakia-at-the-ministry-of-health\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/www.access2meds.eu\\\/es\\\/pagina-de-inicio\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Presentation of New HTA Methodological Guideline for Slovakia at the Ministry of Health\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#website\",\"url\":\"https:\\\/\\\/www.access2meds.eu\\\/\",\"name\":\"ASCERTAIN\",\"description\":\"IMPROVING ACCESS TO INNOVATIVE HEALTH TECHNOLOGIES\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.access2meds.eu\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#organization\",\"name\":\"ASCERTAIN\",\"url\":\"https:\\\/\\\/www.access2meds.eu\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.access2meds.eu\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/ASCERTAIN-logo.svg\",\"contentUrl\":\"https:\\\/\\\/www.access2meds.eu\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/ASCERTAIN-logo.svg\",\"width\":1,\"height\":1,\"caption\":\"ASCERTAIN\"},\"image\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/ASCERTAIN_EU\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/ascertain-eu\\\/\",\"https:\\\/\\\/www.youtube.com\\\/@ascertainproject\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#\\\/schema\\\/person\\\/84cb4791d2eba62e68ecb7f29dba9391\",\"name\":\"Lena Jessen\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Presentation of New HTA Methodological Guideline for Slovakia at the Ministry of Health - ASCERTAIN","description":"On September 30th, the Slovak Ministry of Health hosted a seminar presenting the new national HTA methodological guideline, organized by Professor Tom\u00e1\u0161 Tesa\u0159, with contributions from ASCERTAIN and international experts highlighting the relevance of cost-effectiveness thresholds.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.access2meds.eu\/presentation-of-new-hta-methodological-guideline-for-slovakia-at-the-ministry-of-health\/","og_locale":"es_ES","og_type":"article","og_title":"Presentation of New HTA Methodological Guideline for Slovakia at the Ministry of Health","og_description":"On September 30th, the Slovak Ministry of Health hosted a seminar presenting the new national HTA methodological guideline, organized by Professor Tom\u00e1\u0161 Tesa\u0159, with contributions from ASCERTAIN and international experts highlighting the relevance of cost-effectiveness thresholds.","og_url":"https:\/\/www.access2meds.eu\/presentation-of-new-hta-methodological-guideline-for-slovakia-at-the-ministry-of-health\/","og_site_name":"ASCERTAIN","article_published_time":"2025-10-03T12:58:58+00:00","article_modified_time":"2025-10-03T12:59:01+00:00","og_image":[{"width":2005,"height":1254,"url":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/04\/iStock-825537944_Liderina-scaled-e1680608197278.jpg","type":"image\/jpeg"}],"author":"Lena Jessen","twitter_card":"summary_large_image","twitter_creator":"@ASCERTAIN_EU","twitter_site":"@ASCERTAIN_EU","twitter_misc":{"Escrito por":"Lena Jessen","Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.access2meds.eu\/presentation-of-new-hta-methodological-guideline-for-slovakia-at-the-ministry-of-health\/#article","isPartOf":{"@id":"https:\/\/www.access2meds.eu\/presentation-of-new-hta-methodological-guideline-for-slovakia-at-the-ministry-of-health\/"},"author":{"name":"Lena Jessen","@id":"https:\/\/www.access2meds.eu\/#\/schema\/person\/84cb4791d2eba62e68ecb7f29dba9391"},"headline":"Presentation of New HTA Methodological Guideline for Slovakia at the Ministry of Health","datePublished":"2025-10-03T12:58:58+00:00","dateModified":"2025-10-03T12:59:01+00:00","mainEntityOfPage":{"@id":"https:\/\/www.access2meds.eu\/presentation-of-new-hta-methodological-guideline-for-slovakia-at-the-ministry-of-health\/"},"wordCount":258,"publisher":{"@id":"https:\/\/www.access2meds.eu\/#organization"},"image":{"@id":"https:\/\/www.access2meds.eu\/presentation-of-new-hta-methodological-guideline-for-slovakia-at-the-ministry-of-health\/#primaryimage"},"thumbnailUrl":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/04\/iStock-825537944_Liderina-scaled-e1680608197278.jpg","keywords":["health technologies","healthcare","HTA","iht","innovative health technologies"],"articleSection":["Allgemein"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/www.access2meds.eu\/presentation-of-new-hta-methodological-guideline-for-slovakia-at-the-ministry-of-health\/","url":"https:\/\/www.access2meds.eu\/presentation-of-new-hta-methodological-guideline-for-slovakia-at-the-ministry-of-health\/","name":"Presentation of New HTA Methodological Guideline for Slovakia at the Ministry of Health - ASCERTAIN","isPartOf":{"@id":"https:\/\/www.access2meds.eu\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.access2meds.eu\/presentation-of-new-hta-methodological-guideline-for-slovakia-at-the-ministry-of-health\/#primaryimage"},"image":{"@id":"https:\/\/www.access2meds.eu\/presentation-of-new-hta-methodological-guideline-for-slovakia-at-the-ministry-of-health\/#primaryimage"},"thumbnailUrl":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/04\/iStock-825537944_Liderina-scaled-e1680608197278.jpg","datePublished":"2025-10-03T12:58:58+00:00","dateModified":"2025-10-03T12:59:01+00:00","description":"On September 30th, the Slovak Ministry of Health hosted a seminar presenting the new national HTA methodological guideline, organized by Professor Tom\u00e1\u0161 Tesa\u0159, with contributions from ASCERTAIN and international experts highlighting the relevance of cost-effectiveness thresholds.","breadcrumb":{"@id":"https:\/\/www.access2meds.eu\/presentation-of-new-hta-methodological-guideline-for-slovakia-at-the-ministry-of-health\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.access2meds.eu\/presentation-of-new-hta-methodological-guideline-for-slovakia-at-the-ministry-of-health\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.access2meds.eu\/presentation-of-new-hta-methodological-guideline-for-slovakia-at-the-ministry-of-health\/#primaryimage","url":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/04\/iStock-825537944_Liderina-scaled-e1680608197278.jpg","contentUrl":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/04\/iStock-825537944_Liderina-scaled-e1680608197278.jpg","width":2005,"height":1254},{"@type":"BreadcrumbList","@id":"https:\/\/www.access2meds.eu\/presentation-of-new-hta-methodological-guideline-for-slovakia-at-the-ministry-of-health\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/www.access2meds.eu\/es\/pagina-de-inicio\/"},{"@type":"ListItem","position":2,"name":"Presentation of New HTA Methodological Guideline for Slovakia at the Ministry of Health"}]},{"@type":"WebSite","@id":"https:\/\/www.access2meds.eu\/#website","url":"https:\/\/www.access2meds.eu\/","name":"ASCERTAIN","description":"IMPROVING ACCESS TO INNOVATIVE HEALTH TECHNOLOGIES","publisher":{"@id":"https:\/\/www.access2meds.eu\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.access2meds.eu\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.access2meds.eu\/#organization","name":"ASCERTAIN","url":"https:\/\/www.access2meds.eu\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.access2meds.eu\/#\/schema\/logo\/image\/","url":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/02\/ASCERTAIN-logo.svg","contentUrl":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/02\/ASCERTAIN-logo.svg","width":1,"height":1,"caption":"ASCERTAIN"},"image":{"@id":"https:\/\/www.access2meds.eu\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/ASCERTAIN_EU","https:\/\/www.linkedin.com\/company\/ascertain-eu\/","https:\/\/www.youtube.com\/@ascertainproject"]},{"@type":"Person","@id":"https:\/\/www.access2meds.eu\/#\/schema\/person\/84cb4791d2eba62e68ecb7f29dba9391","name":"Lena Jessen"}]}},"_links":{"self":[{"href":"https:\/\/www.access2meds.eu\/es\/wp-json\/wp\/v2\/posts\/4698","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.access2meds.eu\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.access2meds.eu\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.access2meds.eu\/es\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.access2meds.eu\/es\/wp-json\/wp\/v2\/comments?post=4698"}],"version-history":[{"count":2,"href":"https:\/\/www.access2meds.eu\/es\/wp-json\/wp\/v2\/posts\/4698\/revisions"}],"predecessor-version":[{"id":4710,"href":"https:\/\/www.access2meds.eu\/es\/wp-json\/wp\/v2\/posts\/4698\/revisions\/4710"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.access2meds.eu\/es\/wp-json\/wp\/v2\/media\/1450"}],"wp:attachment":[{"href":"https:\/\/www.access2meds.eu\/es\/wp-json\/wp\/v2\/media?parent=4698"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.access2meds.eu\/es\/wp-json\/wp\/v2\/categories?post=4698"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.access2meds.eu\/es\/wp-json\/wp\/v2\/tags?post=4698"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}